Literature DB >> 30771630

Tuberculosis screening for prospective migrants to high-income countries: systematic review of policies.

A Garner-Purkis1, P Hine2, A Gamage3, S Perera3, M C Gulliford4.   

Abstract

OBJECTIVE: To compare predeparture tuberculosis (TB) screening policies, including screening criteria and screening tests, and visa requirements for prospective migrants to high-income countries that have low to intermediate TB incidence and high immigration. STUDY
DESIGN: Systematic review of policy documents.
METHODS: We systematically identified high-income, high net-migration countries with an estimated TB incidence of <30 per 100,000. After initial selection, this yielded 15 countries which potentially had TB screening policies. We performed a systematic search of governmental and official visa services' websites for these countries to identify visa information and policy documents for prospective migrants. Results were summarized, tabulated, and compared.
RESULTS: Programs to screen for active TB were identified in all 15 countries, but screening criteria and screening tests varied substantially between countries. Prospective migrants' country of origin represented an initial assessment criterion which generally focused on elevated TB incidence based on World Health Organization data but also focused on the countries of origin that sent the most migrants, and this varied between destination countries. Specific categories of migrants represented a second assessment criterion that focused on duration of stay and reasons for migration; the focus of which showed variation between the destination countries. Specific screening tests including medical examination and chest X-rays were used as the final stage of assessment, and there were differences between which tests were used between the destination countries.
CONCLUSIONS: Current approaches to migrant TB screening are inconsistent in their approach and implementation. While this variation might reflect adaptation to local public health situations, it could also indicate uncertainty concerning optimal strategies. Comparative research studies are needed to define the most effective and efficient methods for TB screening of migrants.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Infectious diseases; Migrants; Mycobacterium tuberculosis; Screening

Mesh:

Year:  2019        PMID: 30771630     DOI: 10.1016/j.puhe.2018.12.016

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

1.  Comparable worth of life for all? Conducting and disseminating health economic evaluations for refugees in Germany.

Authors:  Louise Biddle; Katharina Wahedi; Kayvan Bozorgmehr
Journal:  Global Health       Date:  2022-05-12       Impact factor: 10.401

2.  A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar.

Authors:  Fatima Al-Hatimy; Abdulaziz Farooq; Mohamad Al Abiad; Shilpi Yerramsetti; Maryam Ali Al-Nesf; Chidambaram Manickam; Mohammed H Al-Thani; Al-Hareth Al-Khater; Waseem Samsam; Vidya Mohamed-Ali; Mohammed Al-Maadheed
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

3.  Importance of Tuberculosis Screening of Resident Visa Applicants in Low TB Incidence Settings: Experience from Oman.

Authors:  Jeffrey Singh; Seif Al-Abri; Eskild Petersen; Fatma Al Yaqoubi; Khoula Al Rahbi; Lamya Al Balushi; Fatma Al Fahdi; Asma Al Balushi; Farah Mahmmoud M Jawad; Padmamohan J Kurup
Journal:  J Epidemiol Glob Health       Date:  2022-04-25

4.  Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).

Authors:  Katharina Wahedi; Louise Biddle; Kayvan Bozorgmehr
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

5.  Perspectives of Vietnamese, Sudanese and South Sudanese immigrants on targeting migrant communities for latent tuberculosis screening and treatment in low-incidence settings: A report on two Victorian community panels.

Authors:  Chris Degeling; Stacy M Carter; Katie Dale; Kasha Singh; Krista Watts; Julie Hall; Justin Denholm
Journal:  Health Expect       Date:  2020-09-12       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.